AUPH settles voclosporin patent litigation with Teva, delaying potential generic competition in the

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) shares are up during Thursday's premarket session as the c

Aurinia Pharmaceuticals shares rise after settling patent litigation with Teva, which can launch gen

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) today announced that it and its subsidiary, Aurinia Pharm

EDMONTON, Alberta--(BUSINESS WIRE)--Aurinia Settles Patent Litigation with Teva.

Aurinia Pharmaceuticals is running the phase 4 PRESERVE trial in lupus nephritis, which tests combin

RBC Capital analyst Douglas Miehm maintains Aurinia Pharmaceuticals (NASDAQ:AUPH) with a Sector P

Aurinia Pharmaceuticals (AUPH) came out with quarterly earnings of $0.28 per share, beating the Zack

Aurinia Pharmaceuticals (NASDAQ:AUPH) affirms FY2026 sales outlook from $315.000 million-$325.000 mi

Aurinia Pharmaceuticals (NASDAQ:AUPH) reported quarterly earnings of $0.28 per share which beat the

ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)--Aurinia Pharmaceuticals Reports Financial Resul

Biotech stocks are consolidating after a breakout, with bullish insider Wall Street sentiment. AbCel

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced the initiation of PRESERVE, a Phase 4, m

ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) tod

Aurinia (AUPH) might move higher on growing optimism about its earnings prospects, which is reflecte

Indivior, Aurinia, Ironwood, Altimmune and Marker have been highlighted in this Industry Outlook art

Innovation is at its peak in the Zacks Medical-Drugs industry. INDV, AUPH, IRWD, ALT and MRKR may pr

Aurinia (AUPH) saw its shares surge in the last session with trading volume being higher than averag

814,606 common shares acquired for a total transaction value of approximately $12.5 million, based o

Aurinia Pharmaceuticals (AUPH) is positioned for profitable growth, driven by Lupkynis and pipeline

Hazard ratios (HRs) favored treatment with LUPKYNIS for the following individual components of the c

ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)--LUPKYNIS Associated with a Statistically Signif

Aurinia Pharmaceuticals Inc. (AUPH) Shareholder/Analyst Call Prepared Remarks Transcript

Tang Capital Management, LLC announces that on June 2, 2026, it acquired 206,005 common shares (the

Little Falls, New Jersey--(Newsfile Corp. - May 19, 2026) - Alliance Advisors is pleased to congratu

Silver prices surged 7% Monday to the highest since March.

Aurinia Pharmaceuticals (AUPH) came out with quarterly earnings of $0.25 per share, beating the Zack

Aurinia Pharmaceuticals (NASDAQ:AUPH) affirms FY2026 sales outlook from $315.000 million-$325.000 mi

Aurinia Pharmaceuticals (NASDAQ:AUPH) reported quarterly earnings of $0.25 per share which beat the

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), a biopharmaceutical company focused on delivering thera

Aurinia Pharmaceuticals shares are trading higher Monday after announcing a leadership transition se

Aurinia Pharmaceuticals shares are trading lower Thursday afternoon after the lupus-focused drugmake

Aurinia Pharmaceuticals (NASDAQ:AUPH) sees FY2026 sales of $315.000 million-$325.000 million vs $326

Aurinia Pharmaceuticals (NASDAQ:AUPH) reported quarterly earnings of $1.53 per share which beat the

Leerink Partners analyst Joseph Schwartz downgrades Aurinia Pharmaceuticals (NASDAQ:AUPH) from Ou

Jefferies analyst Maury Raycroft upgrades Aurinia Pharmaceuticals (NASDAQ:AUPH) from Hold to Buy

RBC Capital analyst Douglas Miehm downgrades Aurinia Pharmaceuticals (NASDAQ:AUPH) from Outperfor

Gainers SciSparc (NASDAQ: SPRC) shares increased by 28.2% to $5.68 during Monday's after-market

U.S. stock futures were fluctuating on Friday after a mixed close on Thursday. Futures of benchmark

Shares of Herbalife Ltd. (NYSE: HLF) fell sharply in today’s session following weak quarterly earni

Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earning